Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease?

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 3, 2012, Pages 326-330

  Zahodne, Laura B ^a   Bernal Pacheco, Oscar ^a   Bowers, Dawn ^a   Ward, Herbert ^a   Oyama, Genko ^a   Limotai, Natlada ^a   Velez Lago, Frances ^a   Rodriguez, Ramon L ^a   Malaty, Irene ^a   McFarland, Nikolaus R ^a   Okun, Michael S ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; ANTIPARKINSON AGENT; BUSPIRONE; CARBIDOPA PLUS LEVODOPA; CITALOPRAM; CLOZAPINE; DONEPEZIL; DULOXETINE; ENTACAPONE; ESCITALOPRAM; FLUOXETINE; GALANTAMINE; MEMANTINE; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; MONOAMINE OXIDASE B INHIBITOR; PAROXETINE; PRAMIPEXOLE; QUETIAPINE; RASAGILINE; RIVASTIGMINE; ROPINIROLE; ROTIGOTINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; APATHY; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

EID: 84867512470     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11090210     Document Type: Article

References (18)

1. Kirsch-Darrow L, Fernandez HH, Marsiske M, et al: Dissociating apathy and depression in Parkinson disease. Neurology 2006; 67:33-38
2. van Reekum R, Stuss DT, Ostrander L: Apathy: why care? J Neuropsychiatry Clin Neurosci 2005; 17:7-19
3. Remy P, Doder M, Lees A, et al: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128:1314-1322
4. Leentjens AF, Koester J, Fruh B, et al:The effect of pramipexole on mood andmotivational symptoms in Parkinson's disease: ametaanalysis of placebo-controlled studies. Clin Ther 2009; 31:89-98
5. Le Jeune F, Drapier D, Bourguignon A, et al: Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73:1746-1751
6. Chen P, Kales HC, Weintraub D, et al: Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample. J Geriatr Psychiatry Neurol 2007; 20:161-165
7. Sansone RA, Sansone LA: SSRI-induced indifference. Psychiatry (Edgmont) 2010; 7:14-18
8. Hughes AJ, Daniel SE, Kilford L, et al: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
9. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4:134-139
10. Beck AT, Ward CH, Mendelson M, et al: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
11. Visser M, Leentjens AF, Marinus J, et al: Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease. Mov Disord 2006; 21:668-672
12. Wongpakaran N, van Reekum R, Wongpakaran T, et al: Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study. Ann Gen Psychiatry 2007; 6:7
13. McCabe C, Mishor Z, Cowen PJ, et al: Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 2010; 67:439-445
14. Shelton RC, Tomarken AJ: Can recovery from depression be achieved? Psychiatr Serv 2001; 52:1469-1478
15. Corcoran C, Wong ML, O'Keane V: Bupropion in the management of apathy. J Psychopharmacol 2004; 18:133-135
16. Fernandez HH, Chen JJ: Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. Pharmacotherapy 2007; 27:174S-185S
17. Newburn G, Newburn D: Selegiline in the management of apathy following traumatic brain injury. Brain Inj 2005; 19: 149-154
18. Brodaty H, Altendorf A, Withall A, et al: Do people become more apathetic as they grow older? a longitudinal study in healthy individuals. Int Psychogeriatr 2010; 22:426-436